Skip to main content
Top
Published in: Inflammation Research 3-4/2015

01-04-2015 | Original Research Paper

A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development

Authors: Marion C. Dickson, Valerie J. Ludbrook, Hayley C. Perry, Paul A. Wilson, Sam J. Garthside, Michael H. Binks

Published in: Inflammation Research | Issue 3-4/2015

Login to get access

Abstract

Objectives

To investigate Toll-like receptor activation in human skin using tape stripping and imiquimod cream challenges in healthy volunteers.

Subjects, treatment and methods

Seventeen male Caucasian subjects underwent a baseline biopsy on their lower back prior to two tape stripping procedures 7 days apart. Subjects were then treated with 5 % imiquimod for 2 and 4 days on separate sites in the same area. Further biopsies were taken 22–24 h after each challenge and mRNA and microRNA extracted and expression values analysed using robust statistical and pathway analysis methods.

Results

Fifteen of the 17 subjects completed the study according to protocol. No adverse events were associated with the procedures. A significant change (p < 0.05, fold change >1.5 or <−1.5) in mRNA expression of 7,996 genes was evident in biopsies taken at both time points post tape stripping, compared to baseline biopsy expression values. The induction of mRNAs involved in various pathways including adhesion and migration was evident. mRNA markers representing inflammatory cells [e.g., CD14, CD3E (p < 0.0001)] and mRNAs encoding genes regulated by type 1 interferon (IFN) [e.g., MX1, OAS1and CXCL10 (p < 0.0001)] were significantly up-regulated. IFNα and CXCL10 proteins were detectable in exudates released 1 and 4 h post tape stripping. A putative signalling network associating these transcripts and six microRNAs (hsa-miR, -31, -132, -155, 548c, 548n and 574) was identified using a meta-regulation network model. microRNAs not previously associated with IFN signalling have been identified. In contrast, only 223 known transcripts were significantly changed after imiquimod treatment, including CXCL10, and OAS1.

Conclusion

Results suggest that IFN signalling is important in these translational models and novel miRNA may be new targets in the treatment of IFN associated skin disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Guiducci C, Tripodod C, Gong M, Sangaletti S, Colombo MP, Coffman RL, Barrat FJ. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J Exp Med. 2010;207(13):2931–42.CrossRefPubMedCentralPubMed Guiducci C, Tripodod C, Gong M, Sangaletti S, Colombo MP, Coffman RL, Barrat FJ. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J Exp Med. 2010;207(13):2931–42.CrossRefPubMedCentralPubMed
2.
go back to reference Sun S, Rao NL, Venable J, Thurmond R, Karlsson L. TLR7/9 agonists as therapeutics for immune mediated inflammatory disorders. Inflamm Allergy Drug Targets. 2007;6:223–35.CrossRefPubMed Sun S, Rao NL, Venable J, Thurmond R, Karlsson L. TLR7/9 agonists as therapeutics for immune mediated inflammatory disorders. Inflamm Allergy Drug Targets. 2007;6:223–35.CrossRefPubMed
3.
go back to reference Streilein JW, White Lonsberry LW, Bergstresser PR. Depletion of epidermal Langerhans cells and Ia immunogenicity from tape stripped mouse skin. J Exp Med. 1982;155:863–71.CrossRefPubMed Streilein JW, White Lonsberry LW, Bergstresser PR. Depletion of epidermal Langerhans cells and Ia immunogenicity from tape stripped mouse skin. J Exp Med. 1982;155:863–71.CrossRefPubMed
4.
go back to reference Wood LC, Jakcson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90:482–7.CrossRefPubMedCentralPubMed Wood LC, Jakcson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90:482–7.CrossRefPubMedCentralPubMed
5.
go back to reference Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T, Tuting T. Enhanced type I interferon signalling promotes ThI-biased inflammation in cutaneous lupus erythematosus. J Path. 2005;205:435–42.CrossRefPubMed Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T, Tuting T. Enhanced type I interferon signalling promotes ThI-biased inflammation in cutaneous lupus erythematosus. J Path. 2005;205:435–42.CrossRefPubMed
6.
go back to reference Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Derm. 1994;30(4):535–46.CrossRefPubMed Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Derm. 1994;30(4):535–46.CrossRefPubMed
7.
go back to reference Marks DJB, Radulovic M, McCartney S, Bloom S, Segal AW. Modified skin window technique for the extended characterisation of acute inflammation in humans. Inflamm Res. 2007;56(4):168–74.CrossRefPubMedCentralPubMed Marks DJB, Radulovic M, McCartney S, Bloom S, Segal AW. Modified skin window technique for the extended characterisation of acute inflammation in humans. Inflamm Res. 2007;56(4):168–74.CrossRefPubMedCentralPubMed
8.
go back to reference Dickel H, Gambichler T, Kamphowe J, Altmeyer P, Skrygan M. Standardised tape stripping prior to patch testing induces up regulation of HSP90, HSP70, IL-33, TNFα and IL-8/CXCL8 mRNA: new insights into the involvement of ‘alarmins’. Contact Dermat. 2010;63:215–22.CrossRef Dickel H, Gambichler T, Kamphowe J, Altmeyer P, Skrygan M. Standardised tape stripping prior to patch testing induces up regulation of HSP90, HSP70, IL-33, TNFα and IL-8/CXCL8 mRNA: new insights into the involvement of ‘alarmins’. Contact Dermat. 2010;63:215–22.CrossRef
9.
go back to reference Van der Fits L, Mourits S, Voerman JSA, Kant M, Boon L, Laman JD, Cornelissen F, Mus A-M, Florencia E, Prens EP, Lubberts E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL23/IL17 axis. J Immunol. 2009;182:5836–45.CrossRefPubMed Van der Fits L, Mourits S, Voerman JSA, Kant M, Boon L, Laman JD, Cornelissen F, Mus A-M, Florencia E, Prens EP, Lubberts E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL23/IL17 axis. J Immunol. 2009;182:5836–45.CrossRefPubMed
10.
go back to reference Palamara F, Meindl S, Holemann M, Luhrs P, Stingl G, Sibilia M. Identification and characterisation of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol. 2004;173:3051–61.CrossRefPubMed Palamara F, Meindl S, Holemann M, Luhrs P, Stingl G, Sibilia M. Identification and characterisation of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol. 2004;173:3051–61.CrossRefPubMed
11.
go back to reference Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J, Xing X, Nair RP, Voorhees JJ, Elder JT, Wang X-J, Sano S, Prens EP, DiGiovanni J, Pittelkow MR, Ward NL, Gudjonsson JE. Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One. 2011;6(4):e18826.CrossRef Swindell WR, Johnston A, Carbajal S, Han G, Wohn C, Lu J, Xing X, Nair RP, Voorhees JJ, Elder JT, Wang X-J, Sano S, Prens EP, DiGiovanni J, Pittelkow MR, Ward NL, Gudjonsson JE. Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One. 2011;6(4):e18826.CrossRef
12.
go back to reference Chan MP, Zimarowski MJ. Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases. Am J Dermatopathol. 2011;33:523–7.CrossRefPubMed Chan MP, Zimarowski MJ. Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases. Am J Dermatopathol. 2011;33:523–7.CrossRefPubMed
13.
go back to reference Schon MP, Schon M. Imiquimod: mode of action. Br J Derm. 2007;157(s2):8–13.CrossRef Schon MP, Schon M. Imiquimod: mode of action. Br J Derm. 2007;157(s2):8–13.CrossRef
14.
go back to reference Hendriks AGM, Keijsers RRMC, Seyger MMB, van Erp PEJ, van de Kerkhof PCM. Are newly discovered drivers of immune-mediated skin disorders expressed in normal skin regenerating from standardized surface injury? Dermatology. 2014;228(3):255–60.CrossRefPubMed Hendriks AGM, Keijsers RRMC, Seyger MMB, van Erp PEJ, van de Kerkhof PCM. Are newly discovered drivers of immune-mediated skin disorders expressed in normal skin regenerating from standardized surface injury? Dermatology. 2014;228(3):255–60.CrossRefPubMed
15.
go back to reference Wenzel J, Tuting T. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp Dermatol. 2007;16(5):454–63.CrossRefPubMed Wenzel J, Tuting T. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp Dermatol. 2007;16(5):454–63.CrossRefPubMed
16.
go back to reference Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, McManus MT, Rosenfeld MG, Briata P, Gherzi R. LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J. 2009;23(9):2898–908.CrossRefPubMed Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, McManus MT, Rosenfeld MG, Briata P, Gherzi R. LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. FASEB J. 2009;23(9):2898–908.CrossRefPubMed
17.
go back to reference Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F. Boshoff C (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol. 2010;12(5):513–9.CrossRefPubMed Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F. Boshoff C (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol. 2010;12(5):513–9.CrossRefPubMed
18.
go back to reference Xu L, Wen Z, Zhou Y, Lui Z, Li Q, Fei G, Lou J, Ren T. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway. MBoC. 2013;24:42–55. Xu L, Wen Z, Zhou Y, Lui Z, Li Q, Fei G, Lou J, Ren T. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway. MBoC. 2013;24:42–55.
19.
go back to reference Li Q, Li X, Guo Z, Xu F, Xia J, Lui Z, Ren T. MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer. PLoS. 2012;7(11):e48278.CrossRef Li Q, Li X, Guo Z, Xu F, Xia J, Lui Z, Ren T. MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer. PLoS. 2012;7(11):e48278.CrossRef
20.
go back to reference Elton TS, Selemon H, Elton S, Parinandi NL. Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2013;532:1–12.CrossRefPubMed Elton TS, Selemon H, Elton S, Parinandi NL. Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2013;532:1–12.CrossRefPubMed
21.
go back to reference Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN, Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 2009;31(2):220–31.CrossRefPubMedCentralPubMed Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN, Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 2009;31(2):220–31.CrossRefPubMedCentralPubMed
22.
go back to reference O’Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA. 2009;106(17):7113–8.CrossRefPubMedCentralPubMed O’Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA. 2009;106(17):7113–8.CrossRefPubMedCentralPubMed
23.
go back to reference Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001–9.CrossRefPubMed Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001–9.CrossRefPubMed
24.
go back to reference Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(12):2516–22.CrossRefPubMed Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(12):2516–22.CrossRefPubMed
25.
go back to reference Philippe L, Alsaleh G, Bahram S, Pfeffer S, Georgel P. The miR-17 ∼ 92 cluster: a key player in the control of inflammation during rheumatoid arthritis. Immunol Front. 2013. doi:10.3389/fimmu.2013.00070. Philippe L, Alsaleh G, Bahram S, Pfeffer S, Georgel P. The miR-17 ∼ 92 cluster: a key player in the control of inflammation during rheumatoid arthritis. Immunol Front. 2013. doi:10.​3389/​fimmu.​2013.​00070.
26.
go back to reference Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O’Leary JJ, Ruan Q, Johnson DS, Chen Y, O’Neill LAJ. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010;11:141–7.CrossRefPubMed Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O’Leary JJ, Ruan Q, Johnson DS, Chen Y, O’Neill LAJ. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010;11:141–7.CrossRefPubMed
27.
go back to reference Das A, Ganesh K, Khanna S, Sen CK, Roy S. Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J immunol. 2014;192:1120–9.CrossRefPubMed Das A, Ganesh K, Khanna S, Sen CK, Roy S. Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J immunol. 2014;192:1120–9.CrossRefPubMed
28.
go back to reference Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Haibo Z, Tang Y, Shen N. MicroRNA-21 and MicroRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2011;184:6773–81.CrossRef Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Haibo Z, Tang Y, Shen N. MicroRNA-21 and MicroRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2011;184:6773–81.CrossRef
29.
go back to reference Qi J, Qiao Y, Wang P, Li S, Zhao W, Gao C. microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages. FEBS Lett. 2012;586:1201–7.CrossRefPubMed Qi J, Qiao Y, Wang P, Li S, Zhao W, Gao C. microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages. FEBS Lett. 2012;586:1201–7.CrossRefPubMed
Metadata
Title
A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development
Authors
Marion C. Dickson
Valerie J. Ludbrook
Hayley C. Perry
Paul A. Wilson
Sam J. Garthside
Michael H. Binks
Publication date
01-04-2015
Publisher
Springer Basel
Published in
Inflammation Research / Issue 3-4/2015
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-015-0795-z

Other articles of this Issue 3-4/2015

Inflammation Research 3-4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine